{"podcast":{"title":"AJ Bell Money & Markets","slug":"aj-bell-money-markets-773447","podcast_index_feed_id":773447,"rss_url":"https://ajbell.podbean.com/feed.xml","website_url":"https://www.ajbell.co.uk/podcasts","image_url":"https://pbcdn1.podbean.com/imglogo/image-logo/3599140/Logo_2024_update6nt5y.jpg","author":"AJ Bell","episode_count":398,"summary":"The Money & Markets podcast brings you the latest personal finance and stock market insights to help you manage your investment portfolio. To contact us visit ajbell.co.uk For legal info visit ajbell.co.uk/disclosures.","last_synced_at":"2026-06-05T18:18:05.907917+00:00","page_url":"https://stenobird.com/podcast/aj-bell-money-markets-773447"},"episode":{"title":"Investing in weight-loss drugs, and why everyone’s talking about student loans","slug":"investing-in-weight-loss-drugs-and-why-everyone-s-talking-about-student-loans","published_at":"2026-02-13T10:48:19+00:00","page_url":"https://stenobird.com/podcast/aj-bell-money-markets-773447/investing-in-weight-loss-drugs-and-why-everyone-s-talking-about-student-loans","show_page_url":"https://stenobird.com/podcast/aj-bell-money-markets-773447","url":"https://ajbell.podbean.com/e/investing-in-weight-loss-drugs-and-why-everyone-s-talking-about-student-loans/","audio_url":"https://mcdn.podbean.com/mf/web/a8b5i6ahhc5hm833/260211-M_M-WeightlossDrugsStudentLoans-v26o8uf.mp3","summary":"On this episode of the AJ Bell Money & Markets podcast, how financial markets reacted to speculation around the future of Keir Starmer as UK prime minister. [02:00] Dan Coatsworth and Tom Sieber unpack the latest results from Shell, BP and Barclays. [05:05] AI has haunted parts of the stock market once again, with financial comparison websites and insurance brokers the latest victims as investors fear major disruption to their business. [11:12] There was some remarkable news in the pharmaceutical space as Novo Nordisk battled Him & Her’s amid controversy around the launch of copycat weight-loss drugs. The pod team explore the weight loss drug space in more detail and explain why one analyst thinks Greggs is a major loser as people slim down. [15:05] Dan talks to Trevor Polishchuk from Worldwide Healthcare about how Eli Lilly has scored the top slot in the weight-loss drug market [24:13]. Martin Gamble chats to Oliver Kenyon from RTW Investment about other names to watch in this space. [30:13] Charlene Young is on the show to explain why everyone’s talking about student loans. [33:00] Finally, Danni Hewson talks to Pathos Communications about its experiences of listing on the UK stock market and the use of AI in the public relations industry. [45:32]","meta_description":"On this episode of the AJ Bell Money & Markets podcast, how financial markets reacted to speculation around the future of Keir Starmer as UK prime min…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3677,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/aj-bell-money-markets-773447/episodes/investing-in-weight-loss-drugs-and-why-everyone-s-talking-about-student-loans/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/aj-bell-money-markets-773447/investing-in-weight-loss-drugs-and-why-everyone-s-talking-about-student-loans.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}